ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Oct 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
November 2025
Nuclear Technology
October 2025
Fusion Science and Technology
Latest News
Russia withdraws from 25-year-old weapons-grade plutonium agreement
Russia’s lower house of Parliament, the State Duma, approved a measure to withdraw from a 25-year-old agreement with the United States to cut back on the leftover plutonium from Cold War–era nuclear weapons.
B.F. Peterman, J.R. Johnson, R.G.C. McElroy
Fusion Science and Technology | Volume 8 | Number 2 | September 1985 | Pages 2557-2563
Environmental Study | Proceedings of the Second National Topical Meeting on Tritium Technology in Fission, Fusion and Isotopic Applications (Dayton, Ohio, April 30 to May 2, 1985) | doi.org/10.13182/FST85-A24664
Articles are hosted by Taylor and Francis Online.
This paper describes a study on metabolism of inhaled tritiated hydrogen gas (HT) in mammals. Rats and human volunteers were exposed to HT gas for periods from one minute to ten minutes. The amount of HT that was oxidized in vivo was estimated by measuring the concentration of HTO in urine. No significant quantities of tritiated organic compounds resulting from HT gas inhalation were observed in tissues of rats and it is assumed that this holds true for humans also. The fraction of inhaled HT converted to HTO in human volunteers was found to be about 1 × 10−4 indicating that the dose from the HTO that resulted from HT oxidiation is a significant component of the effective dose equivalent.
